US 8188095
Gyrase inhibitors and uses thereof
granted A61PA61P11/00A61P13/02
Quick answer
US patent 8188095 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P11/00, A61P13/02, A61P13/08, A61P17/00